Money Matters: Cost-Effectiveness of Juvenile Drug Court with and without Evidence-Based Treatments

Ashli J. Sheidow, Jayani Jayawardhana, W. David Bradford, Scott W. Henggeler, Steven B. Shapiro

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

The 12-month cost-effectiveness of juvenile drug court and evidence-based treatments within court were compared with traditional Family Court for 128 substance-abusing/dependent juvenile offenders participating in a 4-condition randomized trial. Intervention conditions included Family Court with community services (FC), Drug Court with community services (DC), Drug Court with Multisystemic Therapy (DC/MST), and Drug Court with MST enhanced with a contingency management program (DC/MST/CM). Average cost-effectiveness ratios for substance use and criminal behavior outcomes revealed that economic efficiency in achieving outcomes generally improved from FC to DC, with the addition of evidence-based treatments improving efficiency in obtaining substance use outcomes.

Original languageEnglish
Pages (from-to)69-90
Number of pages22
JournalJournal of Child and Adolescent Substance Abuse
Volume21
Issue number1
DOIs
StatePublished - Jan 2012

Bibliographical note

Funding Information:
This research was supported by grants from the National Institute on Drug Abuse (K23DA015658, r01DA13066), the National Institute on Alcohol Abuse and Alcoholism (r01AA122202), and the Center for Substance Abuse Treatment. Dr. henggeler is a shareholder in MST Services, the MUSC-licensed purveyor organization that facilitates the transport of MST technology and intellectual property.

Keywords

  • contingency management
  • cost-effectiveness
  • juvenile drug court
  • multisystemic therapy
  • substance abuse

ASJC Scopus subject areas

  • Social Psychology
  • Education
  • General Psychology
  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Money Matters: Cost-Effectiveness of Juvenile Drug Court with and without Evidence-Based Treatments'. Together they form a unique fingerprint.

Cite this